Hemoperfusion Cycles in Paraquat Poisoning
For paraquat poisoning, initiate hemoperfusion within 4 hours of exposure and perform a second treatment within 20 hours of exposure, with consideration for multiple sessions (typically 2-3 cycles) guided by urine dithionite testing until negative conversion occurs.
Evidence-Based Approach
The most robust evidence comes from a 2017 retrospective study of 621 patients, which identified that hemoperfusion initiated within 4 hours of exposure followed by a second treatment within 20 hours was an independent predictor of survival 1. This time-dependent approach is critical because paraquat rapidly distributes into tissues, making delayed hemoperfusion largely ineffective.
Recommended Protocol
Initial Hemoperfusion
- First session: Within 4 hours of ingestion
- Duration: 2-4 hours per session
- Second session: Within 20 hours of exposure 1
Additional Cycles
- Survivors typically receive 3-4 sessions on average 2
- Continue sessions based on urine dithionite test (UDT) results - stop when negative conversion occurs, ideally within 10 hours 2
- In severe cases, intensive hemoperfusion (3 times daily for up to 9 consecutive days) has been reported with successful outcomes 3
Critical Timing Considerations
The evidence strongly demonstrates that timing is more important than the number of cycles:
- Hemoperfusion removes approximately 25% of the paraquat dose when performed early 4
- After 12 hours, effectiveness drops dramatically as paraquat redistributes from blood into tissues 5
- Repeated hemoperfusion after 24 hours shows minimal benefit because only 0.4-2% of the total dose remains removable 4
Practical Implementation
Use UDT-Guided Protocol (Resource-Limited Settings)
A 2026 Indian study demonstrated that serial urine dithionite testing provides a practical, low-cost bedside tool for guiding hemoperfusion decisions 2:
- Negative UDT conversion within 10 hours occurred in 77.8% of survivors vs 16.7% of non-survivors
- Continue hemoperfusion until UDT becomes negative
- This approach eliminates need for costly plasma paraquat assays
Combination Therapy
Hemoperfusion combined with continuous renal replacement therapy (CRRT) shows synergistic effects 6:
- HP for direct paraquat adsorption
- CRRT for sustained toxin removal and renal support
- Best outcomes when HP initiated early and combined with 10 days of CVVH 3
Common Pitfalls to Avoid
Delayed presentation: Ingestion-to-door time >4 hours significantly worsens prognosis - only 20% of late presenters survived vs 71.4% of early presenters 2
Relying on repeated late hemoperfusion: Animal studies definitively show that repeated hemoperfusion after initial tissue distribution is futile 4 - one dog died from blood loss complications without benefit
Using hemodialysis as primary detoxification: HD is ineffective for paraquat elimination and may increase mortality; reserve it only for supportive management of acute kidney injury 6
Key Prognostic Factors
Beyond hemoperfusion timing, survival depends on:
- APACHE II score (lower is better) 7
- Development of AKI (92.2% in poor outcomes) 7
- Pulmonary lesion appearance ≤8 days (poor prognostic sign) 1
- Combination therapy with NACS (N-acetylcysteine, ascorbic acid, cyclophosphamide, steroids) 7
The bottom line: Perform 2-3 hemoperfusion cycles with the first within 4 hours and second within 20 hours of exposure, guided by urine dithionite testing until negative, combined with CRRT for optimal outcomes 1, 2.